medication
Instructed in new medication Atenolol to manage hypertension. In addition, warned of possible S/E such as fatigue, lethargy, vertigo, drowsiness, dizziness, fever, bradycardia, hypotension, heart failure, intermittent claudication, nausea, diarrhea, thrombocytopenia, hyperkalemia, hypoglycemia, increased risk of developing type-two diabetes, dyspnea, bronchospasm, rash and leg pain. Instructed to take drug exactly as prescribed at the same time every day. Do not stop drug suddenly but do call prescriber if unpleasant adverse reactions occur. If pulse rate is below 60 beats/minute, stop taking drug and call prescriber. Women: notify prescriber if pregnancy occurs. Drug usage might be discontinued.
Instructed in new medication Atorvastatin to reduce cholesterol levels. In addition, warned of possible S/E such as headache, asthenia, insomnia, peripheral edema, rhinitis, pharyngitis, sinusitis, abdominal pain, dyspepsia, flatulence, nausea, constipation, diarrhea, urinary tract infection, arthritis, arthralgia, myalgia, bronchitis, rash, infection, flu-like syndrome, and allergic reaction.
Instructed in new medication Synthroid and in S/E such as nervousness, insomnia, tremor, headache, fever, tachycardia, palpitations, arrhythmias, angina pectoris, cardiac arrest, diarrhea, vomiting, menstrual irregularities, weight loss, allergic skin reactions, diaphoresis or heat intolerance.
Instructed in new medication Metaproterenol sulfate, to manage bronchial asthma. In addition, warned of possible S/E such as vertigo, headache, nervousness, dry and irritated throat, vomiting, nausea, dry mouth, etc.
Instructed in D/C planning. Instructed to keep MD appointments, take medication exactly as MD ordered and report any S/E and/or S/S to avoid further complications.
Instructed in new medication Levaquin to manage infection. In addition, warned of possible S/E such as headache, insomnia, dizziness, encephalopathy, chest pain, palpitations, vasodilation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, vaginitis, eosinophilia, hypoglycemia, back pain, tendon rupture, rash, pruritus, hypersensitivity reactions, etc. Instructed to take drug as prescribed, even if signs and symptoms disappear. Take drug with plenty of fluids and avoid antacids, sucralfate, and products containing iron or zinc for at least 2 hours before and after each dose. Avoid excessive sunlight, use sun block, and wear protective clothing when outdoors. Stop drug usage and notify prescriber if rash or other S/S of hypersensitivity develop. Notify prescriber if patient experiences pain or inflammation. Tendon rupture can occur with drug. Instructed to Diabetic patient to monitor glucose level and notify prescriber if a hypoglycemia reaction occurs. Notify prescriber if loose stools or diarrhea occurs.
Instructed in new medication Bactroban to manage wound care. In addition, warned of possible S/E such as headache, rhinitis, pharyngitis, burning or stinging with intranasal use, taste perversion, upper respiratory tract congestion, cough with intranasal use, burning pruritis, stinging, rash, pain, and erythema with topical use. Instructed to notify prescriber immediately if no improvement occurs in 3 to 5 days or if condition worsens. Advised not to use other nasal products with Bactroban. Warned patient about local adverse reactions related to drug use. Advised not to use cosmetics or other skin products on treated area.
Instructed in new medication Albuterol to prevent or treat bronchospasm in patients with reversible obstructive airway disease. In addition, warned of possible S/E such as tremor, nervousness, dizziness, insomnia, headache, hyperactivity, weakness, CNS stimulation, malaise, tachycardia, palpitations, hypertension, dry and irritated nose and throat (with inhaled form), nasal congestion, epistaxis, hoarseness, heartburn, nausea, vomiting, anorexia, bad taste in mouth, increased appetite, hypokalemia, muscle cramps, bronchospasm, cough, wheezing, dyspnea, bronchitis, increased sputum or hypersensitivity reactions. Warned patient about possibility of paradoxical bronchospasm. If this occurs, discontinue drug immediately. If more than one inhalation is ordered, instructed to wait at least 2 minutes before repeating procedure. Use of an aero chamber may improve drug delivery to the lungs. If steroid inhaler used, advised to use the bronchodilator first and then advised to wait about 5 minutes before using the steroid. This allows the bronchodilator to open the air passages for maximum effectiveness. Advised to remove canister and wash inhaler with warm, soapy water at least once a week.
Instructed in new medication Tylenol to manage mild pain or fever. In addition, warned of possible S/E such as hemolytuc anemia, neutropenia, leukopenia, pancytopenia, liver damage, jaundice, hypoglycemia, rash and urticaria. Consult prescriber before giving drug to children younger than age 2. Tylenol is only for short-term use. Consult prescriber if it is given to children for longer than 5 days or adults for longer than 10 days. Instructed not to use for marked fever (higher than 103.1 F), fever persisting longer than 3 days, or recurrent fever unless it is directed by prescriber. Warned that high doses or unsupervised long-term use can cause hepatic damage. Excessive ingestion of alcohol may increase the risk of hepatotoxicity. Breast-feeding women: acetaminophen appears in breast milk in low levels (less than 1% of dose). Drug may be used safely if therapy is short-term and does not exceed recommended doses.
Instructed in new medication Glucovance to improve glycemic control in patients with type-two diabetes whose hyperglycemia cannot be controlled with diet and exercise alone. In addition, warned of possible S/E such as headache, dizziness, diarrhea, nausea, vomiting, abdominal pain, hypoglycemia, lactic acidosis, or upper respiratory tract infection. Instructed to take one daily with breakfast and, if twice daily, then at breakfast and dinner. Stop drug and tell prescriber of unexplained hyperventilation, myalgia, malaise, unusual somnolence, or other symptoms of early lactic acidosis. GI symptoms are common with initial drug therapy but GI symptoms that occur after prolonged therapy may be related to lactic acidosis or other serious disease and should be reported promptly. Instructed not to take any other drugs, including OTC drugs, without checking with prescriber.